Valeant Pharma (VRX) Reports Q1 EPS of $2.36; Announces CFO Transition

Go back to Valeant Pharma (VRX) Reports Q1 EPS of $2.36; Announces CFO Transition

Form 8-K Valeant Pharmaceuticals For: Apr 29

April 29, 2015 6:11 AM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

... More

Form 8-K Valeant Pharmaceuticals For: Apr 29

April 29, 2015 6:10 AM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

... More